Eton Pharmaceuticals (ETON)
(Delayed Data from NSDQ)
$8.62 USD
+0.15 (1.77%)
Updated Nov 1, 2024 04:00 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Earnings News For ETON
-
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
-
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
-
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
-
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
-
Eton Pharma (ETON) to Report Q4 Earnings: What's in the Cards?
-
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
-
Eton Pharma (ETON) to Report Q3 Earnings: What's in the Cards?
-
Eton Pharmaceuticals, Inc. (ETON) Tops Q2 Earnings and Revenue Estimates
-
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
-
Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Tops Revenue Estimates
-
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
-
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Surpass Estimates
-
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
-
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Tops Revenue Estimates
-
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
-
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue Estimates
-
Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: Should You Buy?
-
Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Lags Revenue Estimates
-
Analysts Estimate Eton Pharmaceuticals, Inc. (ETON) to Report a Decline in Earnings: What to Look Out for
-
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Misses Revenue Estimates
-
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue Estimates
-
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Meet Estimates
-
Eton Pharmaceuticals, Inc. (ETON) Reports Next Week: Wall Street Expects Earnings Growth